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AbsTrACT
Introduction Phelan-McDermid syndrome (PMS) 
is caused by SHANK3 haploinsufficiency. its wide 
phenotypic variation is attributed partly to the type and 
size of 22q13 genomic lesion (deletion, unbalanced 
translocation, ring chromosome), partly to additional 
undefined factors. We investigated a child with severe 
global neurodevelopmental delay (nDD) compatible 
with her distal 22q13 deletion, complicated by bilateral 
perisylvian polymicrogyria (BPP) and urticarial rashes, 
unreported in PMS.
Methods Following the cytogenetic and array-
comparative genomic hybridization (cgH) detection 
of a r(22) with SHANK3 deletion and two upstream 
duplications, whole-genome sequencing (WgS) in blood 
and whole-exome sequencing (WeS) in blood and saliva 
were performed to highlight potential chromothripsis/
chromoanagenesis events and any possible BPP-
associated variants, even in low-level mosaicism.
results WgS confirmed the deletion and highlighted 
inversion and displaced order of eight fragments, three of 
them duplicated. the microhomology-mediated insertion 
of partial Alu-elements at one breakpoint junction 
disrupted the topological associating domain joining 
NFAM1 to the transcriptional coregulator TCF20. WeS 
failed to detect BPP-associated variants.
Conclusions although we were unable to highlight the 
molecular basis of BPP, our data suggest that SHANK3 
haploinsufficiency and TCF20 misregulation, both 
associated with intellectual disability, contributed to the 
patient’s nDD, while NFAM1 interruption likely caused 
her skin rashes, as previously reported. We provide the 
first example of chromoanasynthesis in a constitutional 
ring chromosome and reinforce the growing evidence 
that chromosomal rearrangements may be more complex 
than estimated by conventional diagnostic approaches 
and affect the phenotype by global alteration of the 
topological chromatin organisation rather than simply by 
deletion or duplication of dosage-sensitive genes.
InTroduCTIon
The Phelan-McDermid syndrome (PMS; 
MIM#606232) is a neurodevelopmental disorder 
caused by the deletion or interruption of SHANK3 
gene at chromosome 22q13,1–5 leading to haplo-
insufficiency of SHANK3 protein, which is a key 
structural component of the glutamatergic post-
synaptic density.6 Patients with PMS mainly exhibit 
neurological and behavioural symptoms including 
hypotonia, intellectual disability (ID), impaired 
language development (delayed or absent speech), 
behavioural features consistent with disorders of 
the autistic spectrum and seizures.
The penetrance and expressivity of these symp-
toms may be variable, with different degrees of 
severity at different ages3 7–9 as well as congenital 
malformations,4 5 even among patients with the 
uniformly-sized recurrent 22q13.3 deletion2 or 
interstitial deletions affecting only SHANK3.3 10
It is still uncertain whether the phenotypic vari-
ability is caused by variants regarding the genes 
and expression controlling elements present on the 
corresponding region of the intact chromosome 22, 
by a genome rearrangement more complex than 
estimated or even by a cryptic mosaic condition of 
the 22q rearrangement. The latter mechanism may 
particularly apply to the PMS individuals in whom 
the distal 22q deletion lies in a ring chromosome. 
Indeed, rings are intrinsically unstable, resulting in 
the continuous production of cells having dupli-
cated rings, broken portions of the original ring or 
even missing the entire chromosome.
In this study, we investigated a patient with a 
de novo ring chromosome 22, present in all the 
50 metaphases analysed, who showed a complex 
cortical brain abnormality and unusual dermatolog-
ical features, in addition to the core phenotype of 
PMS. Since array-CGH had revealed a distal 22q 
deletion and two non-contiguous duplications, we 
performed whole-genome sequencing (WGS) to 
investigate a possible event of chromothripsis/chro-
moanagenesis. WGS confirmed this hypothesis, 
highlighting eight breakpoints along the chromo-
some 22 long arm and disordered assembly of the 
resulting fragments, with disruption of topological 
associating domains (TAD) and breakage of four 
genes.
MeThods
Clinical report
A 3-year-old female child came to our attention 
after a ring chromosome 22 was detected by cytoge-
netics when she was 8 months old. The patient was 
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the first child of healthy unrelated parents with uneventful family 
history. She was born by caesarean section to a 37-year-old mother 
and 32-year-old father at 37 weeks of gestational age because of 
umbilical cord wrapped around her neck. Birth weight was 2000 g 
(10th–25th centile), length 44.5 cm (25th centile), cranial circum-
ference 31 cm (25th centile); APGAR scores were 8/9 at 1’/5’, 
respectively. At birth, she was initially transferred to the intensive 
care unit and then to the neonatal pathology unit for 28 days. 
Hypoglycaemia and thrombocytopaenia were solved in 4 and 12 
days, respectively, while her feeding difficulties, characterised by 
poor sucking, required gavage. In the first months of life, gener-
alised hypotonia and delayed psychomotor development were 
observed. She acquired head control at 12 months, sat at the age of 
13 months, was standing at 20 months and walked with support at 
the age of 24 months. She uttered her first words at 12 months but 
her parents refer no subsequent progression of language. Hyper-
somnia was present since the age of 2 years.
At the age of 22/12 years (26 months), she began to manifest atopic 
dermatitis characterised by recurrent pruritic urticarial rushes on the 
face and the trunk in addition to persistent limb pilaris keratosis. 
Food-specific IgE antibody tests resulted negative and her family 
history of atopy was unremarkable. At last evaluation, at the age of 
3 years, her weight was 12.25 kg (25th centile), height 95.5 cm (75th 
centile), cranial circumference 50.50 cm (75th centile). She showed 
ptosis of her left eye and long face but no major dysmorphic features. 
Griffiths scale scores revealed severe ID (IQ: 24, mental age equiv-
alent 8 months) and language was absent. Poor eye contact and 
stereotypic hand movements characterised her neurological picture. 
Diffuse mild muscular hypotrophy and weakness were present, with 
trunk hypotonia, unsteadiness of orthostatic position and ataxic gait 
with support. Bilateral coxa valga, hyporeflexia in the lower limbs, 
together with bilateral Babinski sign, were present. Orofacial hypo-
tonia, with drooling and bruxism, and severe swallowing disorder 
were observed. She suffered episodes of gastro-oesophageal reflux. 
Kidney ultrasound, urinalysis and function blood tests were normal. 
Atopic dermatitis was still present (figure 1A). The brain 3T MRI 
showed complex brain anomalies including bilateral perisylvian poly-
microgyria (BPP) (figure 1B). The white matter volume was diffusely 
reduced. The third and lateral ventricles were markedly enlarged, 
probably because of a partial stenosis of the aqueduct caused by a 
large cyst compressing the lamina quadrigemina. The corpus callosum 
was thinned. An arachnoid cyst with mass effect compressed the right 
cerebellar hemisphere. EEG recording showed slowing of background 
activity during wakefulness, while the physiologic features (K-com-
plex and spindles) during sleep were rare with irregular morpholo-
gies. Slow waves, of greater amplitude than the background rhythm, 
were present in the posterior areas, bilaterally, without side predom-
inance. On electromyography (EMG) derivation, isolated myoclonic 
jerks were recorded without EEG correlates (figure 1C). She never 
presented episodes of epileptic febrile or non-febrile seizures and no 
antiepileptic drugs were administered so far.
MoleCulAr sTudIes
Genomic DNA was extracted from proband’s, parents’ and 
maternal grandparents’ blood and saliva with standard protocols.
Array-CGh investigations
Array-CGH analysis was performed on proband’s DNA from 
blood using an Agilent Human Genome CGH Microarray Kit 
4×180 k with an overall median probe space of 13 Kb. All 
nucleotide positions refer to the Human Genome, February 
2009 Assembly (hg19). Data analysis was performed using 
Agilent Cytogenomics V.2.5.8.1. High-resolution G-banding 
metaphase chromosomes and interphase nuclei were obtained 
from PHA-stimulated blood lymphocytes cultured for 72 hours, 
according to standard protocols. Dual and three-colour FISH 
experiments with prokaryotic artificial chromosome (PAC) 
probes, selected according to the UCSC Human Genome 
Browser (GRCh37/hg19) and obtained from the human library 
RPCI-4 and 3, were performed as previously described.11 The 
pan-telomeric peptide nucleic acid (PNA) probe (PNA FISH 
kit/Cy3, Dako Denmark A/S) which recognises the consensus 
sequence (TTAGGG)n of human telomeres was hybridised 
according to the manufacturer’s instructions.
Whole-genome sequencing (WGs) and sanger confirmation of 
breakpoint junctions
Sequencing libraries to perform WGS were prepared with Illu-
mina’s TruSeq DNA PCR Free kit (San Diego, California, USA) 
according to manufacturer’s protocol. We obtained an average 
coverage of 42X in the father’s sample and 37X in the proband’s 
sample. Reads from the fastq files were mapped to the human 
reference genome GRCh37/hg19 using Isaac Genome Align-
ment Software (V.iSAAC-03.16.06.06).12 Coverage graphs were 
performed plotting the average coverage of 1000 bp windows 
sliding over the whole chromosome length, in order to identify 
large deletions and duplications in each chromosome. Struc-
tural variants were called using Lumpy (V.0.2.12) and Manta 
(V.0.29.6).13 14 Then these structural variants were visualised 
and manually checked in Integrative Genomics Viewer (IGV) 
genome browser (V.2.3.72) in order to reconstruct chromo-
somes showing chromothripsis events. Sanger sequencing was 
performed in order to verify the structural variations predicted 
by WGS findings. Primer3 software was used to design primers 
for sequencing de novo breakpoint junctions of structural varia-
tions. PCR was performed by using Taq Polymerase (Invitrogen) 
with elongation times of 1 min. Sequencing reads were analysed 
manually to characterise the exact breakpoints.
Whole-exome sequencing (Wes)
To test for any possible constitutional or mosaic mutation that 
could explain the polymicrogyria, proband’s DNA from both 
blood and saliva was analysed by OneSeq protocol, at an average 
coverage of 194.3x and 134.7x, respectively, on an Illumina 
HiSeq2500, as previously described.15 After reads alignment, 
variant calling, annotation and filtering for possible artefacts was 
done as previously reported.16
The sequences of polymicrogyria candidate genes (online 
supplementary table 1 reported in Parrini et al17) were care-
fully examined together with PI4KA.18 Sanger sequencing was 
performed to validate the only variant possibly associated with 
polymicrogyria, SRPX2 at Xq22.1, by using standard methods, 
extending the analysis to the three-generation family members 
and performing X-inactivation investigation.
Topologically associating domains (TAds) analysis
Search for TADs was performed by using the web-based 3D 
Genome Browser.19
resulTs
Cytogenetics investigations
The patient’s karyotype was 46,XX,r(22)(::p11.2>q13::)
dn with no evidence of ring instability in the 50 metaphases 
analysed. Array-CGH showed several copy number changes 
involving the ring chromosome 22, potentially representing a 
complex chromosome rearrangement. The 22q13 band showed 
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a multiple rearrangement pattern: a duplication (dup) followed 
by a normal copy region (nlm), a second duplication and a 
terminal deletion (dup-del) (figure 2). This rearranged region 
(dup-nlm-dup-del) of 21 Mb spanned at least four breakpoints, 
with a copy-number loss of approximately 8.4 Mb and copy-
number gain of approximately 2.5 Mb. Parental origin analysis 
showed that both duplication and deletion involved the paternal 
chromosome 22 (online supplementary table 1).
Genome analysis
Whole-genome sequencing (WGS)
WGS analysis, performed on blood samples from proband and 
father (average coverage 37X and 42X, respectively), revealed 
eight breakpoints in the proband, producing nine fragments from 
A to I at the q arm of chromosome 22 (figure 3A). According 
to array-CGH analysis (figure 2) and visual inspection of chro-
mosome 22 by IGV (Integrative Genome Viewer), fragment B 
(22q11.23–q12.1; size 257 Kb), fragment E (22q13.1–q13.2; 
size 2,4 Mb) and fragment G (22q13.2; size 160 Kb) were found 
to be duplicated, while fragment I (22q13.2q13.33; size 8.4 Mb) 
was deleted. In addition to the copy number variations detected 
by array-CGH (fragments E, G, I), inversions and displaced 
order of fragments were highlighted, indicating a chromoana-
genesis event. In more detail, fragment H (1 kb) appeared to be 
inverted and fused with fragment G (termed as GHinv fusion 
joint), showing a 1 kb length inversion event between the distal 
Figure 1 Patient’s clinical findings: (a) lateral view of the patient showing urticarial rashes on her face. (B) Brain Mri at the age of 3 years showed 
bilateral symmetric areas of polymicrogyric cortex in the posterior part of the Sylvian fissures, extending to the parietal lobes. in these areas, the cortex 
appears thickened and characterised by small gyri (arrows in 2, 3, 4). corpus callosum is thinned. an arachnoid cyst is present in the right part of the 
posterior fossa (4) and posteriorly to the lamina quadrigemina (1). (c) eeg-polygraphic recording at the age of 3 years. the red circles indicate background 
activity during wakefulness, myoclonic jerks on eMg derivation and K-complex and spindles and slow waves during sleep stages 2 and 3–4.
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duplicated and deleted segments (figure 3B, online supplemen-
tary figure 1). Additionally, a copy of fragment G (160 kb) was 
inverted and fused with the start site of fragment D (termed 
as GinvD fusion joint), showing an inverted insertion event 
within chromosome 22 (figure 3B). Sanger sequencing validated 
both GHinv and GinvD rearrangements (online supplemen-
tary figure 2 and table 2) and revealed an unexpected 183 bp 
inverted insertion between fragments G and H of a chromosome 
14 sequence (chr14:105 518 942–105 519 123) (figure 3B), 
consisting of two portions of an AluSq sequence, as denoted by 
the UCSC RepeatMasker track (online supplementary figure 3). 
The breakpoint characteristics of the GHinv junction involved 
a microhomology of 2 bp (5’-GA) in fragment G-chr14 fusion 
junction and a microhomology of 2 bp (5’-TC) with the inser-
tion of a single bp (5’-G) in chr14-Fragment H fusion junction 
(online supplementary figure 4). The breakpoint junction of H-I 
(chr22:42814464) falls within another subfamily of Alu element 
(AluSx3 sequence, as denoted by the UCSC RepeatMasker 
track, online supplementary figure 5). The GinvD rearrange-
ment had a blunt junction without microhomology (figure 3B; 
online supplementary figure 4). Sanger investigations could not 
confirm the other predicted breakpoint-fusions due to the pres-
ence of repeated sequences. Dual-colour and three-colour FISH 
experiments with PACs probes (figure 4C), either in metaphases 
or interphase nuclei, proved that one copy of fragment E was 
an insertion-duplication, located close to the centromere of the 
r(22) (figure 4D). This might explain why we failed to define the 
fusion point between the end of fragment E (chr22: 41 503 612) 
and the repeated pericentromeric sequences (online supplemen-
tary figure 7). The FISH data fit well with the proposed model 
predicting a fusion between fragment E and the centromeric 
region of chromosome 22, thus forming a closed ring structure 
(figure 4D). We also verified the absence of interstitial pan-telo-
meric sequences with a PNA probe (online supplementary figure 
8). Since the 22q deletion and duplications was of paternal 
origin, the father’s DNA was investigated by WGS for the pres-
ence of any genomic rearrangement predisposing to the chromo-
some 22 abnormality in the proband. We detected two tandem 
duplications, located at Chr22: 23 015 179–23 080 761 and 
Chr22: 25 684 091–25 980 630, reported in DGV as well in our 
Figure 2 array cgH results: (a) rearrangement pattern at 22q13: the profile of chromosome 22 shows a terminal deletion of 8.4 Mb at 22q13.2q13.3 
(chr23: 42 817 697–51 219 009 bp) and two duplications at 22q13.1q13.2 (shaded in blue). (B) enlargement of 22q13.1q13.2 showing the normal copy 
region of 1.1 Mb between two duplicated portions of 2.4 Mb (chr22: 39 106 714–41 497 969 bp) and 148 Kb (ch22: 42 663 298–42 810 963 bp).
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Figure 3 (a,B) reconstruction of ring 22 by WgS. (a) coloured arrows indicate the orientation of the nine fragments relative to the normal chromosome 
22 and are shown from proximal (fragment a) to distal (fragment i) with their breakpoints. Duplicated and deleted fragments are indicated by brackets. 
(B) reconstruction of the ring 22; gHinv and ginvD fusion points, confirmed by Sanger sequencing, are indicated by horizontal two-way black arrows. 
Upper: schematic representation of the insertion of the 183 bp alu-sequence from chromosome 14 in the junction of the gHinv rearrangement. Bottom: 
chromosome 22 WgS coverage plot from proband, father and control Dnas showing that the three duplications (shaded in pink for fragment B, blue for 
fragment e and orange for fragment g) and the distal deletion (fragment i), are present in the proband only, whereas the proximal copy number variants 
are common to all. (c,D) FiSH analysis providing positional information on fragment e. Schematic visualisation of the probes’ location on the normal 
chromosome 22 (c) and the ring chromosome 22 (D) (ring (22)), according to WgS data. the light blue, red and green circles indicate the location of the 
differentially labelled probes. Fish results (D): (1) Metaphase dual-colour FiSH analysis: rP4-742c19 (spectrum red, genbank accession: al031846.2, at 
22q13.1), located within fragment e (indicated by the blue arrow), showed two distinct hybridisation signals on the ring chromosome 22 (arrowhead), one 
of them positioned close to the centromere targeted by probe ceP22 (spectrum aqua, SureFish, agilent); (2) DaPi-staining of the partial metaphase showing 
the normal chromosome 22 (arrow) and ring (22) (arrowhead). (3) interphase three-colour FiSH (rP4-742c19, spectrum red, rP3-408n23, spectrum 
green, genbank accession: Z98048, at 22q13.1 and 22q13.2, respectively and ceP22, spectrum aqua, Sure Fish agilent) shows the direct orientation 
of the two fragments e on the ring chromosome (aqua-green-red-green-red). (4) schematic representation of FiSH results on the ring chromosome 22 
model. WgS, whole-genome sequencing. 
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in-house WGS database (5 out of 21 unrelated cases and 1 out 
of 11, respectively).
Analysis of genes and TADs at breakpoint regions
Four of eight breakpoints detected by WGS disrupted four genes 
(figure 3B): EP300 (MIM 602700) has a role in the neurode-
velopmental disorder Rubinstein-Taybi syndrome 2 (RSTS2, 
MIM#613684); NFAM1 (MIM 608740) is involved in immune 
system functioning; MYO18B (MIM 607295) is associated 
with Klippel-Feil syndrome 4 (KSF4, MIM#616549); GTPBP1 
(MIM 602245) encodes a protein belonging to the family of 
GTP-binding proteins. TAD analysis showed that the GHinv 
breakpoint within NFAM1 (figure 2B) lies in a TAD that joins 
NFAM1 to TCF20 (figure 4).
Whole-exome (WES)
WES analysis was conducted on blood and saliva samples 
from the proband and her parents in order to exclude single 
nucleotide variants that could explain the BPP, a sign never 
before reported in PMS. In fact, the coverage obtained by 
WGS (30–40×) could have been insufficient to highlight any 
possible mosaic variant known to be responsible for polymi-
crogyria.20 WES analysis revealed a heterozygous variant in 
the exon 8 of SRPX2 at Xq22.1, NM_014467.2:c.893G>A 
(NP_055282.1:p.Arg298His), in both proband and mother 
as well as in the maternal grandmother (online supplemen-
tary figure 9). This substitution is reported in several data-
bases (dbSNP, ExAC, ESP, COSMIC) and has a frequency 
in the population of about 0.01%. Moreover, it affects a 
highly conserved amino-acid residue of the Sushi/SCR/CCP 
domain (InterPro#IPR000436) but with contrasting predic-
tions of pathogenicity, according to various in silico tools 
(eg, SIFT, Mutation Taster, Align GVGD). Since the BPP 
could also be caused by somatic mosaic variants in PIK3CA, 
we tried to exclude this possibility by analysing proband’s 
blood and saliva DNA by OneSeq, under experimental 
conditions allowing an average coverage higher than 130x. 
The analysis gave normal results. Similarly, careful analysis, 
including manual IGV inspection, of the exonic sequence 
of PI4KA18 and SNAP29,17 21 both on chromosome 22 and 
reported in association with cortex disorders, did not reveal 
any variants.
dIsCussIon
We describe a complex genomic rearrangement associated with 
a constitutional ring chromosome 22 detected in a 3-year-old 
patient with severe neurodevelopmental disorder. Haploinsuffi-
ciency for SHANK3, fitting with the presence of the r(22), led to 
Figure 4 View of the taD region (chr22:42 550 000–42 850 000), disrupted by the gHinv breakpoint located within intron 1 of NFAM1. inferred taD 
boundaries in respect of the gHinv breakpoint (shown with a blue light star) are represented by black hexagons. the taD connects NFAM1 to TCF20. genes 
in black are on the forward strand (+), while those in blue are on the reverse strand (–). taD, topologically associating domain.
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her initial framing within the PMS syndrome. However, the later 
MRI detection of BPP and the occurrence of recurrent episodes 
of scattered atopic dermatitis indicated a more complex molec-
ular basis for her condition. Among the brain-imaging studies in 
patients with PMS, the most frequent abnormalities described 
are thinning of the corpus callosum (36%), white matter 
changes (39%), ventricular dilatation (32%) and arachnoid cysts 
(14%).22 Other findings showed that some patients with PMS 
have severe posterior cerebellar vermis hypoplasia and enlarged 
cisterna magna.23 Indeed, our patient’s complex brain malfor-
mations included many common brain abnormalities frequently 
observed in PMS individuals (thin corpus callosum, reduced 
volume of white matter, enlarged ventricles and arachnoid 
cysts). However, with the limitation that not all subjects with 
PMS have undergone MRI analysis, polymicrogyric cortex has 
never been reported in patients with 22q distal deletions,5 23 24 
suggesting that mechanisms other than simple haploinsufficiency 
for genes located at distal 22q are responsible for it. By WGS and 
confirmatory WES data (the latter in both blood and saliva, at 
a coverage >100 x), we excluded pathogenic variants in genes 
associated with polymicrogyria and cortex abnormalities having 
a frequency <1%, and in theory, also mosaic condition, as most 
commonly reported for PIK3R2.17 20 Indeed, the c.893G>A 
(p.Arg298His) variant in the in SRPX2 gene on chromosome X, 
coding for a protein involved in synaptogenesis of the cerebral 
cortex, was the only one taken into consideration. A variant 
in exon 4 of SRPX2 was previously described in a male patient 
with BPP, his unaffected mother and two maternal aunts with 
mild ID and no MRI abnormality.25 Similarly, our variant was 
present in the unaffected mother and grandmother and X-inac-
tivation studies revealed that the active X carried the variant in 
the proband but not in her mother (online supplementary figure 
9). Amino-acid residue Arg298 is targeted by other missense or 
synonymous variations (namely p.Arg298Ser, p.Arg298Cys and 
p.Arg298Arg), but p.Arg298His is the most frequently observed, 
with 11 hemizygous subjects reported in the gnomAD browser. 
Therefore, based on currently available information, this variant 
does not seem to have a clear pathogenic role.
None of the genes disrupted by the breakpoints of the ring, 
namely EP300, MYO18B, NFAM1 and GTBP1, was associ-
ated with cortex abnormalities, although some of them may 
contribute to severity of the patient’s phenotype.
Regarding NFAM1, encoding a protein regulating B-cell devel-
opment, the 183 bp insertion at GHinv breakpoint within intron 
1, might theoretically impair its two transcript variants. The TAD 
region, disrupted by the GHinv breakpoint, joins NFAM1 to 
TCF20 (figure 4). De novo variants in TCF20 (OMIM 603107), 
encoding a widely expressed transcriptional coregulator struc-
turally and functionally related to RAI1 (OMIM 607642), have 
been implicated in the aetiology of autism spectrum disorders, 
ID/developmental delay, schizophrenia and postnatal over-
growth.26–29 Thus, misregulation of TCF20 as a consequence 
of TAD perturbation may likely contribute to the neurodevel-
opmental features observed in our patient. Two patients with 
haploinsufficiency of NFAM1 resulting from interstitial 22q13.2 
deletion have been reported with atopic dermatitis and urticarial 
rash,30 31 as observed in our patient (figure 1A), but on closer 
examination one of them30 has a terminal deletion that does not 
include NFAM1. With the limitation that RNA was not avail-
able for NFAM1 expression analysis in our patient, we cannot 
exclude that other genes may contribute to the urticarial rashes.
EP300 frameshift mutations were reported in Rubinstein-Taybi 
syndrome 2, with some phenotypic overlap with our patient 
(speech, gross motor delay, feeding/swallowing issues). The 
interruption of MYO18B does not seem to interfere with the 
phenotype of the patient because it is associated with an auto-
somal recessive condition, namely the Klippel-Feil syndrome 4, 
while the function of GTBP1 is still unknown. Altogether, these 
data explain only part of the patient’s clinical picture, including 
the dermatological manifestation. However, it seems likely that 
disruption of the TAD, either as a consequence of the duplica-
tion/deletion regions or the ring conformation itself,32 played an 
equally important role in her clinical manifestations
Chromoanagesis and ring chromosomes
We describe the first case of a constitutional ring chromosome 
derived by a chromoanagenesis event, previously reported only 
in cancer.33 In line with the predominant occurrence of chro-
moanagenesis constitutional events on paternally derived chro-
mosomes,34 our r(22) was of paternal origin and we excluded 
through WGS that any bona fide predisposing rearrangement 
was present on paternal chromosomes 22. According to the 
mechanisms associated with chromothripsis and chromoanasyn-
thesis, both belonging to the novel category of chromoanagenesis 
events,34 35 we have to assume that the rearrangement occurred 
during either paternal gametogenesis or early embryogenesis 
by isolation of a chromosome 22 within a micronucleus or, 
alternatively, as a consequence of the formation of a chromatin 
bridge interconnecting two daughter cells.36 In the first case, 
chromosome mis-segregation might have led to the trapping of 
chromosome 22 within the micronucleus, as well described in 
chromothripsis, while in the second the occurrence of a dicen-
tric chromosome 22, pter>q13::q13-pter, possibly secondary to 
telomeric crisis, would have promoted chromothripsis events, as 
previously proposed in cancer genomes.37 38 The sequences at the 
breakpoints of our chromosome 22 are consistent with repair-
based mechanisms, although further complexity was added at 
the GHinv fusion point by a 183 bp insertion from chromosome 
14, containing two partial Alu elements, in contrast to the full 
length 300 bp Alu sequence.39 The sequence at the junction of 
AluSq insertion, did not resemble L1 endonuclease consensus 
site (5′-YYYY/RR-3′ where Y=pyrimidine, R=purine) nor its 
additional variations,40 41 making unlikely any L1 endonuclease 
role in the rearrangement. According to all these features at 
GHinv junction, we might predict an endonuclease-independent 
non-classical Alu insertion42 with a potential role in DSB repair. 
An Alu-Alu mediated insertion may also be an option since a 
second Alu was detected at H-I breakpoint (online supplemen-
tary figure 5) as well as in other chromothripsis/chromoanasyn-
thesis rearrangements.43 44
Ring chromosomes are unstable pieces of circular chromatin 
that, as a consequence of sister chromatid exchanges, may 
lead, at least in vitro, to a mosaic condition with different cells 
carrying the entire duplicated or deleted ring chromosome or 
part of it.45 This in vivo instability should result in massive 
cell death, in turn causing the so-called ring syndrome that, 
independently from the chromosome involved, would cause 
extreme growth failure without major malformations, with 
only a few or no minor anomalies and mild to moderate ID.46 
Although the existence of this syndrome remains highly hypo-
thetical, a compensatory uniparental disomy mechanism has 
been demonstrated in induced pluripotent stem cells  (iPSCs) 
obtained from patient fibroblasts containing deleted ring 
chromosomes, with loss of cells containing the abnormal chro-
mosome and duplication of the wild type homologue.47 What-
ever the meaning of this cell-autonomous correction of ring 
chromosomes in vivo, it seems clear that circular chromatin 
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structures are potentially related to decompensation of 
cellular homeostasis via massive gene deregulation. In our 
study, where no ring chromosome instability was highlighted 
at least in blood, we were unable to detect the molecular basis 
for the patient’s BPP, although we can hypothesise that it may 
be linked to insufficient production during embryogenesis of 
proteins encoded by some chromosome 22 genes with a role in 
the formation of the brain cortex.
Although rearrangements more complex than the classical 
model, which considers the circular conformation a consequence 
of the deletion of either chromosome end, have been reported,48 
it is likely that other ring chromosomes may be generated by 
a mechanism such as the one we describe here. This hypoth-
esis might also explain the genotype–phenotype discrepancies 
reported for other ring chromosomes, particularly those of chro-
mosomes 14 and 20, in which the severe phenotype cannot be 
explained based on the deleted region.49 50
ConClusIon
We demonstrate for the first time the occurrence of a constitu-
tional chromoanagenesis event resulting in the formation a ring 
chromosome, with both copy number losses and gains, leading 
to a PMS phenotype associated with BPP and atopic dermatitis 
with urticarial rashes. The outcome of concurrent deletions, 
duplications, gene interruptions and TAD is a dramatically 
complex phenotype. This study reinforces the growing evidence 
that chromosomal rearrangements (1) may be not as simple as 
they appear by conventional diagnostic approaches and (2) affect 
the phenotype by global alteration of the topological chromatin 
organisation rather than simply by the deletion or duplication of 
dosage-sensitive genes.
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